Final answer:
The nurse should monitor for tachycardia option (A) as an adverse effect of albuterol in an asthma patient, as it can stimulate beta-1 receptors in the heart, potentially leading to an increased heart rate.
Step-by-step explanation:
The nurse caring for a client who has asthma and is receiving albuterol should monitor the client for several potential adverse effects, one of which is significant in the context of albuterol administration. The correct option is tachycardia option (A), which is an increase in heart rate. Albuterol is a beta-2 agonist, and while its primary action is on the lungs to encourage bronchodilation and ease breathing, it can also stimulate beta-1 receptors in the heart as an off-target effect. This can lead to an increased heart rate.
While albuterol can cause other side effects such as hypotension or hypertension, and potentially affect blood glucose levels, these are not as commonly monitored for compared to tachycardia in the context of asthma treatment. The other options, bradycardia (reduced heart rate) and elevated blood glucose levels, are not typically direct effects of albuterol.